Risk of Stroke During Long-Term Anticoagulant Therapy in Patients After Myocardial Infarction
Ann Neurol 39:301-307, 2811996., Azar,A.J.,et al, 1996
Clinicopath Conf
Cerebral Amyloid Angiopathy, Case 22-1996, NEJM 335:189-196996., , 1996
The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin
Ann Int Med 124:970-979, Fihn,S.D.,et al, 1996
Bleeding During Antithrombotic Therapy in Patients with Atrial Fibrillation
Stroke Prevention in Atrial Fib Invest, Arch Int Med 156:409-4161996., , 1996
A Double-Blind Study of Subcut Dihydroergotamine vs Subcut Sumatriptan in Treat of Acute Migraine
Arch Neurol 53:180-184, Winner,P.,et al, 1996
Myasthenic Symptoms in Patients with Mitochondrial Myopathies
Muscle & Nerve 18:1338-1340995., Forestier,N.L.,et al, 1995
Neurodegeneration and Diabetes:UK Nationwide Study of Wolfram (DIDMOAD) Syndrome
Lancet 1458-1463, Barrett,T.G.,et al, 1995
Cost-Effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients with Nonvalvular Atrial Fibrillation
JAMA 274:1839-1845, Gage,B.F.,et al, 1995
Oral Sumatriptan-Associated Transmural Myocardial Infarction
Neurol 45:2274-2276, O'Connor,P.&Gladstone,P., 1995
Acetylcholine Receptor Antibodies in Patients with Graves'Ophthalmopathy
J Neuro-Ophthalmol 15:166-170, Jacobson,D.M., 1995
The Use of Sumatriptan in Patients with Monoamine Oxidase Inhibitors
Neurol 45:1039-1040, Diamond,S., 1995
Oral Sumatriptan in Prevent Headache Recurr after Trmt of Migraine with Subcut Sumatriptan
Neurol 45:1505-1509, Rappoport,A.M.,et al, 1995
Oral Sumatriptan for the Acute Treatment of Migraine:Eval of Three Dosage Strengths
Neurol 45:S5-S9, Cutler,N.,et al, 1995
Oral Sumatriptan is Effective & Well Tolerated for the Acute Trmt of Migraine:A Multictr Study
Neurol 45:S10-S14, S31995., Sargent,J.,et al, 1995
Oral Sumatriptan for the Long-Term Treatment of Migraine:Clinical Findings
Neurol 45:S15-S20, Rederich,G.,et al, 1995
Cardiac Arrest Following the Use of Sumatriptan
Neurol 45:1211-1213, Kelly,K.M., 1995
Dopamine, Dystonia, and the Deficient Co-Factor
Lancet 345:1130, Williams,A.C., 1995
Psychosis in Advanced Parkinson's Disease:Treatment with Ondansetron, a 5-HT3 Receptor Antagonist
Neurol 45:1305-1308, Zoldan,J.,et al, 1995
Myasthenia Gravis During Interferon Alfa Therapy
Neurol 45:382-383, Batocchi,A.P.,et al, 1995
The Impact of New Pharmaceutical Agents on the Cost of Neurologic Care
Neurol 45:569-572, Gunderson,C.H., 1995
Analgesic Headache
BMJ 310:479-480, Olesen,J., 1995
Clinicopath Conf
Qunidine-Induced Thrombocytopenia, Cerebral Hemorrhage, Case 15-1995, NEJM 332:1363-137095., , 1995
Oral Anticoagulants and Intracranial Hemorrhage, Facts and Hypotheses
Srroke 26:1471-1477, Hart,R.G.,et al, 1995
The Warfarin-Aspirin Symptomatic Intracranial Disease Study
Neurol 45:1488-1493, Chimowitz,M.I.,et al, 1995
Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves
NEJM 333:11-17, 541995., Cannegieter,S.C.,et al, 1995
The Effect of Nimodipine on Essential Tremor
Neurol 45:1523-1525, Biary,N.,et al, 1995
Dentatorubral-Pallidoluysian Atrophy:Clin Features Closely Related to Unstable Expansion of Trinucleotide (CAG) Repeat
Ann Neurol 37:769-775, Ikeuchi,T.,et al, 1995
Apolipoprotein E Genotype in Diverse Neurodegenerative Disorders
Ann Neurol 38:131-135, Schneider,J.A.,et al, 1995
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
NEJM 332:993-997, 10251995., Khamashta,M.A.,et al, 1995
Electroencephalographic Findings in Hashimoto's Encephalopathy
Neurol 45:977-981, Henchey,R.,et al, 1995
Optimal Oral Anticoag Therapy in Pts with Nonrheumatic Atrial Fib & Recent Cerebral Ischemia
European Atrial Fib Study Group, NEJM 333:5-10, 54995., , 1995
Sneddon's Syndrome is a Thrombotic Vasculopathy:Neuropathologic and Neuroradiologic Evidence
Neurol 45:557-560, Geschwind,D.H.,et al, 1995
Stroke Prevention Therapies and Management of Patient Subgroups
Neurol 45:S19-S24, Raps,E.C.&Galetta,S.L., 1995
Drugs and Surgery in the Prevention of Ischemic Stroke
NEJM 332:238-248, Barnett,H.J.M.,et al, 1995
Machado Joseph Disease Maps to Same Region of Chromosome 14 as Spinocerebellar Ataxia Type 3 Locus
J Med Genet 32:25-31, Twist,E.C.,et al, 1995
Magnetic Resonance Imaging of Brain Iron in Health and Disease
J Neurol Sci 134:19-26,1, Vymazal,J.,et al, 1995
Pharmacogenetics and Drug Metabolism of Newer Antidepressant Agents
J Clin Psychiatry 55:38-45, DeVane,C.L., 1994
Treatment of Radiation-Induced Nervous System Injury with Heparin and Warfarin
Neurol 44:2020-2027, Glantz,M.J.,et al, 1994
Trinucleotide Repeat Expansion in Neurological Disease
Ann Neurol 36:814-822, LaSpada,A.R.,et al, 1994
Phenytoin and Ranitidine Interaction
Ann Int Med 120:892-893, Tse,C.S.T.&Iagmin,P., 1994
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
Stroke 25:2315-2328, Mayberg,M.R.,et al, 1994
Paraneoplastic Temporal Lobe Epilepsy with Testicular Neoplasm and Atypical Amnesia
neurol 44:1270-1274, Ahern,G.L.,et al, 1994
Dopa-Responsive Dystonia:Pathological and Biochemical Observations in a Case
Ann Neurol 35:396-402, 3811994., Rajput,A.H.,et al, 1994
Is There a Problem with Long Term Use of Sumatriptan in Acute Migraine?
BMJ 308:113, Osborne,M.J.,et al, 1994
Patent Foramen Ovale and Brain Infarct:Echocardiographic Predictors, Recurrence, and Prevention
Stroke 25:782-786, Hanna,J.P.,et al, 1994
A Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine in Acute Ischemic Hemispheric Stroke
Stroke 25:1348-1353, Kaste,M.,et al, 1994
A Follow-up Survey of Clinical Practices for the Use of Heparin, Warafarin, & Aspirin
Neurol 44:618-621, Alberts,M.J.,et al, 1994
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Ann Int Med 120:897-902, Hylek,E.M.&Singer,D.E., 1994
Medical Treatment for Stroke Prevention
Ann Int Med 121:41-55, Matchar,D.B.,et al, 1994
Differences in the Pattern of Hippocampal Neuronal Loss in Normal Ageing and Alzheimer's Disease
Lancet 344:769-772, West,M.J.,et al, 1994